Gilead Sciences, Inc. (NASDAQ:GILD) has had a considerably better year than the broader market. The stock has surged by over 24% since the start of the year, compared with a 14% return for the S&P 500. The rally has changed the valuation equation. Yahoo Finance recently put Gilead's normalized…
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.